Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in from biologics discovery and development through to production and supply chain management.

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Vaccines

Uncovering the Latest Trends in Vaccine Development and Technology: Advances in Biotechnology and Vaccines

Read More
Vaccines

Strengthening Preparedness for the Next Pandemic: Interview with Ramin Sabet-Azad, CMC Lead, CEPI

How do we prepare for the next pandemic?
Read More
Vaccines

Vaccine Production for Better Global Access

How were the COVID-19 vaccines developed so fast? And why were some countries left behind?
Read More
Vaccines

Pioneers of COVID-19 mRNA Vaccine Win Nobel Prize

Professors Katalin Karikó and Drew Weissman have been awarded the 2023 Nobel Prize in Medicine for their contributions to the development of the COVID-19 mRNA vaccine.
Read More
Vaccines

Personalised Cancer Vaccines: Tailored Immunotherapy for Precision Treatment 

We take a look at what personalised cancer vaccines are, how they are developed, and how they are changing the field of immunotherapy.
Read More
Vaccines

How Will Commercialisation Impact COVID-19 Vaccine Prices in the US?

We take a look at how the commercialisation of COVID-19 vaccines in the US will impact the price of the vital therapeutic.
Read More
Vaccines

World Malaria Day 2023: Breakthroughs in Malaria Vaccinations

April 25th marks World Malaria Day, an opportunity to raise awareness about the disease’s impact and efforts to control and prevent it.
Read More
Vaccines

In Vivo Model Design and Assay Selection to Aid in Progression from Preclinical to Clinical

Nexelis discussed the preclinical stage of vaccine development at Vaccines EU 2022, highlighting that the choices made during this stage will impact the rest of the development process.
Read More
Vaccines

Carterra: High-Throughput SPR Technology

Read More
Vaccines

MIT Team Create AI-Generated Universal COVID Vaccine

New COVID variants are still a significant risk; but could an AI-generated universal COVID vaccine be the key to overcoming this?
Read More
Vaccines

The EMA’s Vaccines Working Party: The New Authority on Vaccines

The Vaccines Working Party was established last year by the EMA, but what are its main tasks, and how are they looking to achieve them?
Read More
Vaccines

The Race for an RSV Vaccine Approval

Things are heating up in the race to pinch the first FDA approval of an RSV vaccine, as Moderna joins Pfizer and GSK in the running.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics